Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Research (AACR) Epigenetics Conference Nasdaq:ONTX

Press/Media

Period4 Mar 2018

Media coverage

1

Media coverage

  • TitleOnconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Research (AACR) Epigenetics Conference Nasdaq:ONTX
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date4/03/18
    PersonsLewis Silverman
View all 1
View less